Physician profile
Fred L Bishop
NPI 1417927575
$3,488.94
in general payments reported to CMS, 2019-2025
36 companies · $14.19 in 2025
The $14.19 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,160 · 2020: $767 · 2021: $366 · 2022: $259 · 2023: $597 · 2024: $327 · 2025: $14.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $582.75 | 2019-2024 | Repatha, Otezla, Prolia |
| Novo Nordisk INC | $284.26 | 2019-2024 | Wegovy |
| Lilly USA, LLC | $283.68 | 2019-2024 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $254.87 | 2019-2023 | Hyqvia |
| Abbvie INC. | $243.83 | 2019-2023 | Ubrelvy, Dalvance |
| Astrazeneca Pharmaceuticals LP | $232.55 | 2019-2020 | |
| Pfizer INC. | $185.31 | 2019-2024 | |
| Astellas Pharma US INC | $170.65 | 2019-2024 | Veozah |
| Amarin Pharma, INC. | $136.94 | 2019-2020 | |
| Allergan, INC. | $129.40 | 2020-2021 | |
| Optinose US, INC. | $80.24 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $74.27 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $67.54 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.39 | 2020-2021 | |
| Glaxosmithkline, LLC. | $62.05 | 2023-2024 | Shingrix |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $57.51 | 2023-2024 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $52.60 | 2019-2023 | |
| Corcept Therapeutics | $48.85 | 2023 | Korlym |
| Silk Road Medical, INC. | $46.39 | 2020 | |
| Janssen Pharmaceuticals, INC | $44.73 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $44.17 | 2019-2023 | Eliquis |
| Genentech USA, INC. | $37.87 | 2020 | |
| Eisai INC. | $36.52 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $34.99 | 2023-2024 | Nuedexta |
| Ironshore Pharmaceuticals INC. | $31.63 | 2019 | |
| Avanir Pharmaceuticals, INC. | $28.04 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.61 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $23.14 | 2019 | |
| Grifols USA, LLC | $19.79 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $19.21 | 2022 | |
| Mylan Specialty L.P. | $16.51 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.21 | 2021 | |
| Exact Sciences Corporation | $15.46 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $14.19 | 2025 | Varithena Administration Pack |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.99 | 2019 | |
| Merck Sharp & Dohme LLC | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.